Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why have UK doctors been deterred from prescribing Avastin?

× No keyword cloud information.

7 in total

1. Off-label use of bevacizumab for wet age-related macular degeneration in Europe.

Authors: Tomas Bro; Magdalena Derebecka; Øystein Kalsnes Jørstad; Andrzej Grzybowski
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2019-12-30 Impact factor: 3.117

2. Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association.

Authors: V Levent Karabaş; Ecem Önder Tokuç; Figen Şermet
Journal: Turk J Ophthalmol Date: 2022-06-29

3. A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.

Authors: William Hollingworth; Tim Jones; Barnaby C Reeves; Tunde Peto
Journal: BMJ Open Date: 2017-10-22 Impact factor: 2.692

4. One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource.

Authors: Katrin Fasler; Gabriella Moraes; Siegfried Wagner; Karsten U Kortuem; Reena Chopra; Livia Faes; Gabriella Preston; Nikolas Pontikos; Dun Jack Fu; Praveen Patel; Adnan Tufail; Aaron Y Lee; Konstantinos Balaskas; Pearse A Keane
Journal: BMJ Open Date: 2019-06-21 Impact factor: 2.692

5. Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration.

Authors: Katrin Fasler; Dun Jack Fu; Gabriella Moraes; Siegfried Wagner; Eesha Gokhale; Karsten Kortuem; Reena Chopra; Livia Faes; Gabriella Preston; Nikolas Pontikos; Praveen J Patel; Adnan Tufail; Aaron Y Lee; Konstantinos Balaskas; Pearse A Keane
Journal: Br J Ophthalmol Date: 2019-10-14 Impact factor: 4.638

6. The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective.

Authors: Freekje van Asten; Charlotte T J Michels; Carel B Hoyng; Gert Jan van der Wilt; B Jeroen Klevering; Maroeska M Rovers; Janneke P C Grutters
Journal: PLoS One Date: 2018-05-17 Impact factor: 3.240

7. Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.

Authors: Andreas Vilhelmsson; Shai Mulinari
Journal: J Public Health (Oxf) Date: 2018-09-01 Impact factor: 2.341

7 in total